BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11246660)

  • 1. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
    Gilboe IM; Kvien TK; Husby G
    J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls.
    Gilboe IM; Kvien TK; Husby G
    J Rheumatol; 1999 Aug; 26(8):1694-700. PubMed ID: 10451064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associates of health status in patients with systemic lupus erythematosus.
    Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
    J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus.
    Karlson EW; Liang MH; Eaton H; Huang J; Fitzgerald L; Rogers MP; Daltroy LH
    Arthritis Rheum; 2004 Jun; 50(6):1832-41. PubMed ID: 15188360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study.
    Verschueren P; Esselens G; Westhovens R
    Scand J Rheumatol; 2009; 38(3):166-72. PubMed ID: 19169906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health.
    Kievit W; Welsing PM; Adang EM; Eijsbouts AM; Krabbe PF; van Riel PL
    Arthritis Rheum; 2006 Oct; 55(5):745-50. PubMed ID: 17013821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between health-related quality of life and SLE activity and damage in children over time.
    Moorthy LN; Peterson MG; Hassett AL; Baratelli M; Chalom EC; Hashkes PJ; Hong S; Reiff A; Lehman TJ
    Lupus; 2009 Jun; 18(7):622-9. PubMed ID: 19433463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S; Kvien TK; Uhlig T
    J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.